Review
Open access
Aug 2026
Lipoprotein(a) in Personalized Cardiovascular Prevention: Risk Stratification, Coronary Artery Calcium, and Emerging Lp(a)-Lowering Therapies
A practical, evidence-based synthesis of Lp(a) biology, contemporary guideline recommendations, integrated risk stratification using PREVENT and CAC, current management, and emerging Lp(a)-targeted therapies for use across primary care and cardiology practice are provided.
A. Syed, Samuel Michalak, I. Potulapati et al.
· Journal of Clinical Medicine · 0 citations